Xin Lang Cai Jing·2026-01-11 14:01Group 1 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash purchase and capital increase, aiming for rapid capacity expansion to meet growing downstream demand [2] - Huiru Technology specializes in the R&D, production, and sales of high-performance electrolytic copper foil, with a current production capacity of 20,000 tons per year [2] - East China Pharmaceutical's subsidiary, Daor Biotechnology, has its product DR10624 included in the list of breakthrough therapeutic varieties, targeting severe hypertriglyceridemia [3][18] - DR10624 is a globally first-of-its-kind long-acting tri-specific agonist, showing excellent efficacy in reducing triglycerides and eliminating liver fat in clinical trials [3][18] Group 2 - Xiantan Co. reported a 9.41% year-on-year increase in chicken product sales revenue, reaching 529 million yuan, with sales volume up by 6.76% [4][19] - Jiamei Packaging's stock will resume trading on January 12 after completing a review during its suspension, with a significant price increase of 230.48% during the suspension period [5][20] - Xianle Health plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange, considering the interests of existing shareholders [6][21][22] Group 3 - China Shipbuilding Defense expects a net profit increase of 149.61% to 196.88% for 2025, projecting a profit of 940 million to 1.12 billion yuan [7][23] - Daotong Technology anticipates a net profit growth of 40.42% to 45.10% for 2025, with a projected profit of 900 million to 930 million yuan [8][24] - Huace Navigation forecasts a net profit increase of 14.84% to 18.27% for 2025, estimating a profit of 670 million to 690 million yuan [9][25] Group 4 - Luokai Co. won a procurement project from State Grid Fujian Electric Power, with a total contract value of approximately 48.2 million yuan [10][26] - Minhe Co. reported a 65.22% year-on-year increase in the sales volume of commodity broiler chicks, totaling approximately 29.66 million chicks, with sales revenue up by 53.09% [11][27] - Zhenghai Bio obtained a medical device registration certificate for calcium silicate bio-ceramic oral bone repair materials, suitable for alveolar bone defect repair [12][28] - Three Gorges Energy reported a cumulative total power generation increase of 5.99% for 2025, with a total generation of 762.61 billion kWh [13][29] - Huisheng Bio expects a net profit of 235 million to 271 million yuan for 2025, marking a turnaround from a loss in the previous year [14][30]